Paris, France · Founded 2022 · Privately Held (backing)
Developer of a bacterial detection technology designed to develop technological tools to help the food and beverage industry. Spore.Bio is based in Paris, France and was founded in 2022. Its last reported valuation was $60.6 million in Feb 2025. It has raised $31.7 million.
Last reported valuation
$60.6M
Oct 2026
Priced at
—
Total raised
$31.7M
Last round
—
Cap table — not yet on record
Spore.Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Spore.Bio with a free account
·The complete investor list: 23 names
·Watch Spore.Bio: the Monday email on marks, rounds and moves
